In vitro pharmacological characterization of a novel unbiased <scp>NOP</scp> receptor‐selective nonpeptide agonist <scp>AT</scp>‐403
Federica Ferrari(University of Ferrara), Nurulain T. Zaveri(Astraea Therapeutics (United States)), David G. Lambert(Griffith University), Davide Malfacini(University of Bonn), Claudio Trapella(University of Ferrara), V. Blair Journigan(Astraea Therapeutics (United States)), Renzo Guerrini(Meyer Children's Hospital), Mark F. Bird(University of Leicester), Girolamo Calò(University of Padua)
Cited by 31
Related Papers
The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1
|Epilepsia|2010|1.7k
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Pharmacology of nociceptin and its receptor: a novel therapeutic target
|British Journal of Pharmacology|2000|432
Somatic Mutations in Cerebral Cortical Malformations
|New England Journal of Medicine|2014|394